Gotenba, Japan

Nobuaki Kato


Average Co-Inventor Count = 6.1

ph-index = 4

Forward Citations = 33(Granted Patents)


Location History:

  • Shizuoka, JP (1994 - 2006)
  • Gotenba, JP (2004 - 2009)

Company Filing History:


Years Active: 1994-2009

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Nobuaki Kato

Introduction

Nobuaki Kato is a prominent inventor based in Gotenba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on indole derivatives and antiandrogenic agents. With a total of 6 patents to his name, Kato's inventions have the potential to impact medical treatments significantly.

Latest Patents

Kato's latest patents include an indole derivative having a heterocycle and a mono- or diazaindole derivative. This compound is represented by a general formula that includes various substituents, demonstrating its complexity and potential applications. The indole derivative exhibits COX-2 inhibitory activity, making it useful as a pharmaceutical agent, particularly as an anti-inflammatory treatment. Additionally, he has developed an antiandrogenic agent, which also holds promise for therapeutic use.

Career Highlights

Kato is associated with Chugai Seiyaku Kabushiki Kaisha, a company known for its commitment to innovative pharmaceutical solutions. His work has not only advanced the understanding of chemical compounds but has also paved the way for new treatments in the medical field.

Collaborations

Throughout his career, Kato has collaborated with notable colleagues, including Hiroharu Matsuoka and Noriaki Maruyama. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Nobuaki Kato's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator. His work continues to influence the development of new medical treatments, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…